{"id":"https://openalex.org/W4392107464","doi":"https://doi.org/10.53879/id.61.01.14236","title":"MOLECULAR FIELD ANALYSIS AND DYNAMIC SIMULATION STUDIES OF 1,5-DISUBSTITUTED PYRAZOLINE-BASED MAO-A INHIBITORS FOR THE MANAGEMENT OF DEPRESSION","display_name":"MOLECULAR FIELD ANALYSIS AND DYNAMIC SIMULATION STUDIES OF 1,5-DISUBSTITUTED PYRAZOLINE-BASED MAO-A INHIBITORS FOR THE MANAGEMENT OF DEPRESSION","publication_year":2024,"publication_date":"2024-01-28","ids":{"openalex":"https://openalex.org/W4392107464","doi":"https://doi.org/10.53879/id.61.01.14236"},"language":"en","primary_location":{"id":"doi:10.53879/id.61.01.14236","doi":"https://doi.org/10.53879/id.61.01.14236","is_oa":false,"landing_page_url":"https://doi.org/10.53879/id.61.01.14236","pdf_url":null,"source":{"id":"https://openalex.org/S2764981170","display_name":"INDIAN DRUGS","issn_l":"0019-462X","issn":["0019-462X","3048-7161"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4353105718","host_organization_name":"Indian Drug Manufacturers' Association (IDMA)","host_organization_lineage":["https://openalex.org/P4353105718"],"host_organization_lineage_names":["Indian Drug Manufacturers' Association (IDMA)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"INDIAN DRUGS","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5046516730","display_name":"Abhimannu Shome","orcid":"https://orcid.org/0000-0002-1468-7830","observed_orcids":["https://orcid.org/0000-0002-1468-7830"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abhimannu Shome","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066089435","display_name":"Pooja A. Chawla","orcid":"https://orcid.org/0000-0001-7844-9172","observed_orcids":["https://orcid.org/0000-0001-7844-9172"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pooja A. Chawla","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050340395","display_name":"Naresh Kumar Rangra","orcid":"https://orcid.org/0000-0001-6118-4710","observed_orcids":["https://orcid.org/0000-0001-6118-4710"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Naresh K. Rangra","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027831636","display_name":"Volkan Ey\u00fcpo\u011flu","orcid":"https://orcid.org/0000-0001-9108-3558","observed_orcids":["https://orcid.org/0000-0001-9108-3558"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Volkan Eyupoglu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5014005561","display_name":"Ravi Rawat","orcid":"https://orcid.org/0000-0001-6510-1046","observed_orcids":["https://orcid.org/0000-0001-6510-1046"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ravi Rawat","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1349,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.34849171,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":93},"biblio":{"volume":"61","issue":"01","first_page":"18","last_page":"37"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12023","display_name":"Cholinesterase and Neurodegenerative Diseases","score":0.0032999999821186066,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mao-a-inhibitors","display_name":"MAO-A inhibitors","score":0.9419999718666077},{"id":"https://openalex.org/keywords/depression","display_name":"depression","score":0.6100000143051147},{"id":"https://openalex.org/keywords/pyrazoline-derivatives","display_name":"pyrazoline derivatives","score":0.8240000009536743},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.9290000200271606},{"id":"https://openalex.org/keywords/molecular-dynamics-simulation","display_name":"molecular dynamics simulation","score":0.9610000252723694},{"id":"https://openalex.org/keywords/clorgyline","display_name":"clorgyline","score":0.8870000243186951},{"id":"https://openalex.org/keywords/antidepressant-drug-design","display_name":"antidepressant drug design","score":0.5690000057220459}],"concepts":[{"id":"https://openalex.org/C2910293678","wikidata":"https://www.wikidata.org/wiki/Q2889652","display_name":"Clorgyline","level":4,"score":0.8430642485618591},{"id":"https://openalex.org/C164126121","wikidata":"https://www.wikidata.org/wiki/Q766383","display_name":"Quantitative structure\u2013activity relationship","level":2,"score":0.7599533796310425},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5570275187492371},{"id":"https://openalex.org/C112887158","wikidata":"https://www.wikidata.org/wiki/Q169324","display_name":"Hydrogen bond","level":3,"score":0.5485785603523254},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.4124210774898529},{"id":"https://openalex.org/C32909587","wikidata":"https://www.wikidata.org/wiki/Q11369","display_name":"Molecule","level":2,"score":0.24948707222938538},{"id":"https://openalex.org/C2776024655","wikidata":"https://www.wikidata.org/wiki/Q410867","display_name":"Monoamine oxidase","level":3,"score":0.2008705735206604},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.17184191942214966},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.53879/id.61.01.14236","doi":"https://doi.org/10.53879/id.61.01.14236","is_oa":false,"landing_page_url":"https://doi.org/10.53879/id.61.01.14236","pdf_url":null,"source":{"id":"https://openalex.org/S2764981170","display_name":"INDIAN DRUGS","issn_l":"0019-462X","issn":["0019-462X","3048-7161"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-4"],"host_organization":"https://openalex.org/P4353105718","host_organization_name":"Indian Drug Manufacturers' Association (IDMA)","host_organization_lineage":["https://openalex.org/P4353105718"],"host_organization_lineage_names":["Indian Drug Manufacturers' Association (IDMA)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"INDIAN DRUGS","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":37,"referenced_works":["https://openalex.org/W80643428","https://openalex.org/W1194080544","https://openalex.org/W1539372622","https://openalex.org/W1572629057","https://openalex.org/W1984344128","https://openalex.org/W1990220309","https://openalex.org/W1990728481","https://openalex.org/W2005439632","https://openalex.org/W2010233441","https://openalex.org/W2012851909","https://openalex.org/W2012890086","https://openalex.org/W2027836189","https://openalex.org/W2052001291","https://openalex.org/W2060079863","https://openalex.org/W2063808837","https://openalex.org/W2076277579","https://openalex.org/W2086189477","https://openalex.org/W2088863821","https://openalex.org/W2101714106","https://openalex.org/W2107572441","https://openalex.org/W2114429947","https://openalex.org/W2114949911","https://openalex.org/W2127064468","https://openalex.org/W2134996660","https://openalex.org/W2135445988","https://openalex.org/W2291443053","https://openalex.org/W2470620817","https://openalex.org/W2549286116","https://openalex.org/W2617750324","https://openalex.org/W3092849554","https://openalex.org/W3128377774","https://openalex.org/W3186766279","https://openalex.org/W4205208574","https://openalex.org/W4239761798","https://openalex.org/W4248146001","https://openalex.org/W4248973601","https://openalex.org/W4283078854"],"related_works":["https://openalex.org/W2073766911","https://openalex.org/W4387742987","https://openalex.org/W7213292604","https://openalex.org/W3096781431","https://openalex.org/W4391366627","https://openalex.org/W6958106538","https://openalex.org/W7135085672","https://openalex.org/W4379052873","https://openalex.org/W4281743066","https://openalex.org/W1985404921"],"abstract_inverted_index":{"Depression,":[0],"along":[1],"with":[2,28,39,104,112,131,154,177],"grief":[3],"and":[4,61,108,114,136,188,192,215],"anxiety,":[5],"is":[6],"currently":[7],"one":[8],"of":[9,25,147,164,174,229,236],"the":[10,20,33,51,65,87,141,160,178,201,205,219,227,234],"most":[11,34,202],"common":[12],"mental":[13],"illnesses.":[14],"It":[15],"was":[16,84,197],"placed":[17],"25th":[18],"among":[19,86],"major":[21],"diseases.":[22],"QSAR":[23,36,66],"(CoMFA)":[24],"37":[26],"compounds":[27,71],"MAO-A":[29,57,231],"inhibitory":[30],"activity":[31],"yielded":[32],"significant":[35],"model,":[37],"m.3,":[38],"r2":[40],"=":[41,46],"0.963,":[42],"SDEC=":[43],"0.129,":[44],"q2":[45],"0.742,":[47],"SDEP=":[48],"0.34.":[49],"Using":[50],"lead":[52],"likeness":[53],"matrix,":[54],"thirty-seven":[55],"1,5-disubstituted":[56],"inhibitors":[58,232],"were":[59,72,98],"developed":[60],"tested":[62],"based":[63],"on":[64],"models.":[67],"The":[68],"top":[69,88],"13":[70,89],"identified.":[73],"Furthermore,":[74,116],"compound":[75,121],"2B":[76,122,149,162,196],"(\u0394G:":[77],"-10.3":[78],"kcal":[79],"mol-1,":[80],"RMSD:":[81],"0.151":[82],"\u00c5)":[83],"selected":[85],"hits":[90],"obtained":[91],"from":[92],"molecular":[93],"docking":[94],"experiments.":[95,206],"Significant":[96],"interactions":[97,111],"also":[99],"observed,":[100],"including":[101],"\u03c0-\u03c0":[102],"contacts":[103],"Phe208,":[105],"Tyr444,":[106],"Trp407,":[107],"hydrogen":[109,169],"bond":[110],"Ala68":[113],"Tyr69.":[115],"dynamic":[117],"modelling":[118],"demonstrated":[119],"that":[120],"(0.11":[123],"nm)":[124],"has":[125],"higher":[126],"overall":[127],"stability":[128],"than":[129,157,171],"clorgyline,":[130],"a":[132],"lower":[133],"RMSD":[134],"value,":[135],"may":[137],"reach":[138],"equilibrium":[139],"in":[140,213,216,218],"final":[142],"20-25":[143],"ns.":[144],"In":[145],"terms":[146],"RMSF,":[148],"produced":[150],"around":[151],"0.34":[152],"nm":[153],"less":[155],"variation":[156],"clorgyline.":[158],"Throughout":[159],"simulation,":[161],"(No.":[163,173],"H-bond:":[165,175],"6)":[166],"had":[167],"more":[168],"bonding":[170],"clorgyline":[172],"3)":[176],"highest":[179],"occupancy,":[180],"i.e.":[181],"117.39%":[182],"for":[183,186,190,233],"GLU216,":[184],"29%":[185],"TYR444,":[187],"49%":[189],"PRO72,":[191],"so":[193],"on.":[194],"Compound":[195],"proven":[198],"to":[199,226],"be":[200,211],"essential":[203],"throughout":[204],"These":[207],"new":[208],"chemicals":[209],"will":[210,223],"optimized":[212],"vitro":[214],"vivo":[217],"future.":[220],"This":[221],"study":[222],"surely":[224],"contribute":[225],"development":[228],"novel":[230],"treatment":[235],"depression.":[237]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2024-02-24T00:00:00"}